Patient-reported severity of dry eye and quality of life in diabetes.

dry eye ocular surface retinopathy symptoms

Journal

Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 2 2019
pubmed: 19 2 2019
medline: 19 2 2019
Statut: epublish

Résumé

The purpose of the study was to assess the relationship between patient-reported severity of dry eye disease (DED), quality of life (QoL), presence of diabetic retinopathy (DR) and length of disease duration in people with type 1 diabetes mellitus (DM1) and type 2 diabetes mellitus (DM2). A survey of 152 people (110 with and 42 without diabetes). All participants completed the Ocular Surface Disease Index (OSDI) and Dry Eye-related Quality of Life Score (DEQS) questionnaires. Forty-four percent of all diabetic subjects reported dry eye symptoms, compared to 29% in the control group. Patients with DM2 reported dry eye symptoms more frequently than those with DM1 (55% and 27% respectively, Dry eye symptoms are associated with reduced QoL and are more common in people with DM2 than in DM1, irrespective of DR status. Routine clinical screening for severe DED could potentially allow for a timely and more effective treatment and could contribute to mitigating the dry eye-associated reduction in QoL in those with DM2.

Identifiants

pubmed: 30774302
doi: 10.2147/OPTH.S184173
pii: opth-13-217
pmc: PMC6354694
doi:

Types de publication

Journal Article

Langues

eng

Pagination

217-224

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

Ophthalmology. 2000 Apr;107(4):631-9
pubmed: 10768324
Ophthalmology. 2000 May;107(5):967-74
pubmed: 10811092
Arch Ophthalmol. 2000 May;118(5):615-21
pubmed: 10815152
Br J Ophthalmol. 2002 Dec;86(12):1347-51
pubmed: 12446361
Ophthalmology. 2003 Jun;110(6):1096-101
pubmed: 12799232
Ophthalmology. 2003 Jul;110(7):1412-9
pubmed: 12867401
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4753-61
pubmed: 14578396
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1737-42
pubmed: 15161834
Ophthalmologica. 2004 Sep-Oct;218(5):350-5
pubmed: 15334017
Am J Ophthalmol. 2005 Mar;139(3):498-503
pubmed: 15767060
Ocul Surf. 2006 Jul;4(3):137-45
pubmed: 16900269
Optometry. 2006 Nov;77(11):554-8
pubmed: 17145567
Am J Ophthalmol. 2007 Mar;143(3):409-15
pubmed: 17317388
Diabetes Care. 2007 Jul;30(7):1895-7
pubmed: 17372147
Ocul Surf. 2007 Apr;5(2):75-92
pubmed: 17508116
Ocul Surf. 2007 Apr;5(2):93-107
pubmed: 17508117
Eye (Lond). 2009 Mar;23(3):688-93
pubmed: 18309341
BMC Ophthalmol. 2008 Jun 02;8:10
pubmed: 18513455
Clin Ophthalmol. 2009;3:405-12
pubmed: 19688028
Ophthalmic Res. 2010;43(1):11-7
pubmed: 19829007
Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):2050-64
pubmed: 21450919
Clinicoecon Outcomes Res. 2012;4:307-12
pubmed: 23091391
Curr Ophthalmol Rep. 2013 Jun;1(2):51-57
pubmed: 23710423
J Diabetes Complications. 2013 Sep-Oct;27(5):459-62
pubmed: 23726741
Clin Exp Ophthalmol. 2014 Apr;42(3):242-8
pubmed: 23927383
JAMA Ophthalmol. 2013 Oct;131(10):1331-8
pubmed: 23949096
Biomed Res Int. 2013;2013:309723
pubmed: 24024186
Cornea. 2014 Feb;33(2):215-8
pubmed: 24326332
Clin Ophthalmol. 2014 Mar 10;8:507-15
pubmed: 24648714
Eye Contact Lens. 2015 Jan;41(1):44-50
pubmed: 25232992
Diabetes Care. 2014 Oct;37(10):e210-1
pubmed: 25249675
World J Diabetes. 2015 Feb 15;6(1):92-108
pubmed: 25685281
Dtsch Arztebl Int. 2015 Jan 30;112(5):71-81; quiz 82
pubmed: 25686388
Int J Ophthalmol. 2015 Apr 18;8(2):358-64
pubmed: 25938056
J Diabetes Metab Disord. 2015 Apr 29;14:39
pubmed: 26020035
J Diabetes Res. 2015;2015:189525
pubmed: 26247036
Cornea. 2015 Dec;34(12):1534-40
pubmed: 26488630
Br J Ophthalmol. 2016 Jul;100(7):924-928
pubmed: 26500330
Clin Exp Ophthalmol. 2016 May;44(4):278-88
pubmed: 26661628
Ophthalmic Physiol Opt. 2016 Mar;36(2):140-51
pubmed: 26890703
Oman J Ophthalmol. 2015 Sep-Dec;8(3):151-6
pubmed: 26903719
J Ophthalmol. 2016;2016:8201053
pubmed: 27213053
Ophthalmic Physiol Opt. 2017 Mar;37(2):191-201
pubmed: 28211183
Optom Vis Sci. 2017 Jun;94(6):688-693
pubmed: 28538336
Eye (Lond). 2017 Nov;31(11):1550-1555
pubmed: 28622318
Br J Ophthalmol. 2018 May;102(5):674-679
pubmed: 28821553
Clin Exp Ophthalmol. 2018 Aug;46(6):608-615
pubmed: 29345402
BMC Ophthalmol. 2018 May 10;18(1):117
pubmed: 29747621
Ophthalmologe. 1994 Apr;91(2):235-9
pubmed: 8012143
Am J Ophthalmol. 1997 Dec;124(6):723-8
pubmed: 9402817

Auteurs

Md Kaosar Yazdani-Ibn-Taz (MK)

School of Health and Life Sciences, Glasgow Caledonian University (GCU), Glasgow G4 0BA, UK, myazda200@caledonian.ac.uk.

Myint Myint Han (MM)

School of Health and Life Sciences, Glasgow Caledonian University (GCU), Glasgow G4 0BA, UK, myazda200@caledonian.ac.uk.

Sven Jonuscheit (S)

School of Health and Life Sciences, Glasgow Caledonian University (GCU), Glasgow G4 0BA, UK, myazda200@caledonian.ac.uk.

Andrew Collier (A)

School of Health and Life Sciences, Glasgow Caledonian University (GCU), Glasgow G4 0BA, UK, myazda200@caledonian.ac.uk.
Diabetes Day Centre, University Hospital Ayr, Ayr KA6 6DX, UK.

Jane E Nally (JE)

School of Health and Life Sciences, Glasgow Caledonian University (GCU), Glasgow G4 0BA, UK, myazda200@caledonian.ac.uk.

Suzanne Hagan (S)

School of Health and Life Sciences, Glasgow Caledonian University (GCU), Glasgow G4 0BA, UK, myazda200@caledonian.ac.uk.

Classifications MeSH